Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

24.40
Delayed Data
As of Apr 28
 -0.20 / -0.81%
Today’s Change
17.92
Today|||52-Week Range
36.83
-29.89%
Year-to-Date

Today’s Trading

Previous close24.60
Today’s open24.50
Day’s range24.08 - 24.65
Volume519,219
Average volume (3 months)1,168,818
Market cap$840.5M
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-107.53%
Earnings growth (this year)+6.78%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+27.21%
P/E ratioNM
Price/Sales2.25
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
MYOVMyovant Sciences Ltd-0.05-0.38%
EDITEditas Medicine Inc-0.58-2.99%
JNCEJounce Therapeutics ...+1.46+5.44%
NDRMNeuroderm Ltd+0.07+0.26%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$532.1M
Annual profit (last year)-$2.5M
Net profit margin-0.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts